Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

NCT02876835 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3872

Enrollment

INDUSTRY

Sponsor class

Conditions

Anaemia

Interventions

DRUG: Daprodustat
DRUG: Darbepoetin alfa
DRUG: Placebo
DRUG: Iron Therapy

Sponsor

GlaxoSmithKline